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Once thought only as storage for excess nutrients, adipose tissue has been shown to be a dynamic organ
implicated in the regulation of many physiological processes. There is emerging evidence supporting
differential roles for visceral and subcutaneous white adipose tissue in maintaining health, although how
these roles are modulated by the aging process is not clear. However, the proposed beneﬁcial effects of
subcutaneous fat suggest that targeting maintenance of this tissue could lead to healthier aging. In this
study, we tested whether alterations in adipose function with age might be associated with changes in
oxidative stress. Using visceral and subcutaneous adipose from C57BL/6 mice, we discovered effects of
both age and depot location on markers of lipolysis and adipogenesis. Conversely, accumulation of
oxidative damage and changes in enzymatic antioxidant expression with age were largely similar be-
tween these two depots. The activation of each of the stress signaling pathways JNK and MAPK/ERK was
relatively suppressed in subcutaneous adipose tissue suggesting reduced sensitivity to oxidative stress.
Similarly, pre-adipocytes from subcutaneous adipose were signiﬁcantly more resistant than visceral-
derived cells to cell death caused by oxidative stress. Cellular respiration in visceral-derived cells was
dramatically higher than in cells derived from subcutaneous adipose despite little evidence for differ-
ences in mitochondrial density. Together, our data identify molecular mechanisms by which visceral and
subcutaneous adipose differ with age and suggest potential targetable means to preserve healthy adipose
aging.
Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Adipose tissue shows dramatic alterations in growth and me-
tabolism that are modulated by development, diet, environment
and age. While adipose tissue has historically been thought to
exist largely as a benign storage vesicle, there is now clear evi-
dence that adipose has varied physiological roles that include
regulation of metabolism, immunity and endocrine function
among others. In addition, it is increasingly clear that cellular
lineage and/or anatomical location has dramatic effect on the basic
biology of adipose with a classic example being the differences
between brown adipose tissue (BAT) and white adipose tissue
(WAT). However, even amongst adipose tissue broadly character-
ized as WAT, adipose depots that develop in different locations of
the body may dramatically differ in physiological function. Foraccess article under the CC BY-NC
p Institute for Longevity and
Center at San Antonio, 15355
: þ1 210 562 6110.
n).example, excess accumulation of visceral adipose in the abdominal
cavity is associated with increased risk of metabolic dysfunction,
diabetes, cardiovascular disease and mortality [1,2]. On the other
hand, subcutaneous adipose, primarily located in depots under the
skin, appears to be relatively benign and may in some cases ac-
tually be beneﬁcial for overall health [3,4]. Moreover, transplan-
tation of subcutaneous adipose tissue to visceral locations can
improve glucose metabolism, including increasing insulin sensi-
tivity in rodent models [5]. Therefore, understanding how to
promote maintenance of “healthy” subcutaneous adipose over
visceral may have signiﬁcant effects in improving health.
With age, WAT undergoes signiﬁcant changes in growth reg-
ulation, metabolism, and inﬂammation that may drive the pa-
thophysiology of some age-related diseases. Human fat mass is
thought to typically increase throughout a large percentage of life
in humans, though there is signiﬁcant redistribution of these
stores preferentially towards visceral adipose [6–8]. Many of the
normal functions of WAT, including those that modulate glucose
metabolism, also become dysregulated with age in part due to the
accumulation of senescent adipocytes [9,10]. The accumulation of-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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pro-inﬂammatory state associated with mammalian aging. Adi-
pose tissue may play a signiﬁcant role in the regulation of the
aging process itself as the beneﬁcial effects of caloric or dietary
restriction have been thought to be promoted in part by a reduc-
tion in adipose tissue throughout life [11]. More directly, surgical
removal of visceral adipose tissue can extend lifespan in rodents as
well as improve insulin sensitivity [5,12]. Interestingly, ablation of
the insulin receptor in adipose tissue in mice (FIRKO) causes local
insulin resistance in adipose tissue but tends to improve whole
animal insulin sensitivity and extends median and maximum
lifespan [13].
The metabolic consequences of changes in adipose mass are
generally clear, though the mechanisms by which these are driven
remain elusive. Over the last decade, there has been growing
evidence that oxidative stress caused by the accumulation of
adipose tissue may have a role in the etiology of metabolic dys-
functions commonly associated with obesity [14,15]. While accu-
mulation of visceral adipose is clearly associated with increased
oxidative stress, this relationship in other adipose depots is less
clearly deﬁned [16]. Some have suggested that fat accumulation
may accelerate mammalian aging, at least at the tissue/organ le-
vels, through oxidative stress-mediated processes [17,18]. How
these processes are altered by the normal dynamics of aging in
different adipose depots has yet to be determined. In this study,
we ﬁrst addressed how visceral and adipose tissue differed in their
changes in oxidative stress, antioxidant function and oxidant re-
sponse in young, aged, and old C57BL/6 mice. We then addressed
the potential that differential metabolic and mitochondrial de-
mands may play in this process using primary cell culture models.
Together, our data identify substantial differences between visc-
eral and subcutaneous adipose depots that suggests these tissues
have differential means to deal with the metabolic and oxidative
demands of aging.2. Methods
2.1. Animals
All mice used in this study were male C57BL/6J either born and
reared in house or obtained from the aged rodent colony main-
tained by the National Institute on Aging. For body and tissue
weights, only mice from in-house colonies were used. Molecular
assays were performed on tissues from both groups of mice. All
mice were sacriﬁced and tissues were collected in the morning
(09:00–12:00) after receiving food and water ad libitum through
the night and were euthanized by CO2 asphyxiation followed by
cervical dislocation. At sacriﬁce, tissues were weighed and frozen
immediately in liquid N2 then stored at 80 °C until use. For the
purposes of this study, mice classiﬁed as Youngwere between 6–
9 months of age, those classiﬁed as Aged were 15–19 months of
age, and those classiﬁed as Old were 24–30 months of age.
2.2. Assessment of protein content and activity
Frozen samples from visceral (perirenal depots) and sub-
cutaneous (both inguinal and subscapular depots) were homo-
genized in RIPA buffer with added protease and phosphatase in-
hibitors (Thermo Scientiﬁc, Rockford, IL, USA) then centrifuged at
14,000g at 4 °C for 15 min. The total protein content of super-
natants from this procedure was measured by Pierce BCA (Thermo
Scientiﬁc) and equal amounts of protein were prepared in a
loading buffer containing 2-mercaptoethanol, heated, then sepa-
rated electrophoretically by SDS-PAGE and then transferred to
polyvinylidene diﬂuoride (PVDF) membrane (Millipore, Billerica,MA, USA). Primary antibodies to individual proteins used in this
study were: phospho-HSL, total HSL, PPARγ, phospho-JNK, total
JNK/SAPK, cytochrome c (Cell Signaling, Beverly MA), LPL (Santa
Cruz Biotechnologies, Santa Cruz CA), GAPDH, Sod1, Sod2, Gpx1
(Abcam, Cambridge MA). We also used the Mitosciences OxPhos
cocktail (Abcam) to determine relative levels of mitochondrial
proteins NDUFB8, CII-30, CIII-core2, and CIV-I simultaneously All
alkaline phosphatase-conjugated secondary antibodies (anti-rab-
bit and anti-mouse) were purchased through Santa Cruz Bio-
technologies. Individual protein bands on immunoblots were de-
tected using ECL reagent (Thermo Scientiﬁc) and analyzed using
ImageJ. To measure levels of protein-bound 4-HNE, we separated
total cellular protein homogenates by SDS-PAGE with subsequent
Western blot for 4-HNE (Abcam). The total signal of all visible
bands within a lane was determined using Image J. Kinetic enzyme
assays for superoxide dismutase and glutathione peroxidase ac-
tivity were performed using kits for each as per manufacturer’s
instructions (Cayman Chemicals, Ann Arbor MI). Kinetic enzyme
activity assays were performed using adipose lysates prepared in
RIPA buffer and triplicate samples for each were measured in
sample sizes of 50 mg/protein per assay. For phospho ERK and total
ERK measurements, protein homogenates in RIPA buffer measured
by ELISA assays performed as per manufacturer’s instructions
(Abcam).
2.3. Pre-adipocyte (PA) isolation and growth
Visceral (epididymal) and subcutaneous (both inguinal and
subscapular) adipose depots were collected from young (3–6
month) C57BL/6 mice. Pre-adipocytes were isolated and cultured
using methods previously described [19,20]. In brief, fresh adipose
depots were minced and digested in media containing collagenase
Type II for 30 min, then ﬁltered through sterile mesh. After cen-
trifugation, the resultant cell pellet was washed with 1X DPBS and
suspended in DMEMþ10% fetal calf serumþantibiotics (Life
Technologies, Carlsbad CA). The entire pellet was plated in 60 mm
tissue culture dishes and placed in water-jacketed, humidiﬁed
incubator maintained at 37 °C, with 5% CO2 in air, and ambient
(21%) O2 in air. Cells were monitored for conﬂuence, then trypsi-
nized, counted and re-seeded into T25 or T75 ﬂasks at a cell
density of 10,000 cells/cm2 ﬂask area. All cells were tested after
the second or third passage using this protocol. To assay cell stress
resistance, we utilized a modiﬁed version of a protocol previously
described for ﬁbroblast cultures [21,22]. In brief, 25,000 cells/well
were seeded into 96 well plates in 100 mL DMEMþ10% fetal calf
serumþantibiotics and allowed to adhere for 48 h. Wells were
then washed and fresh DMEM (þFCS and antibiotics) containing
either paraquat or tert-butyl hydroperoxide was added for a per-
iod of 6 h after which cells were washed and fresh DMEM (þFCS
and antibiotics) was replaced. After 18 h, cell viability was mea-
sured using WST-1 as per manufacturer’s instruction (Roche Life
Science, Indianapolis IN).
2.4. Mitochondrial bioenergetics
Mitochondrial respiration was measured in intact pre-adipo-
cyte cell lines using a Seahorse Bioscience XF24 Extracellular Flux
Analyzer (North Billerica, MA. USA). For each experiment, cells
were seeded at a density of 40,000 cells per well. We used a
standard running medium of unbuffered DMEM medium þ4.5 g/L
glucose and L-glutamine, with 1 mM sodium pyruvate (Invitrogen,
Carlsbad, CA). The BOFA mitochondrial function assay was used as
described by Seahorse Biosciences and utilized sequential injec-
tions of Oligomycin, FCCP and Antimycin A. All cell culture ex-
periments were performed at ambient (21%) O2 and immediately
following each assay, cells were lysed to quantify total protein
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content and no signiﬁcant difference in protein between visceral
and subcutaneous derived lines. Oxygen consumption measure-
ments are expressed as pmole/min and normalized to protein
content. Integrated area under the curves were determined using
the included Seahorse analysis software.
2.5. Statistical analyses
For aging studies, data were analyzed by two factor ANOVA
testing the effect of age (group) and depot. When applicable, post-
hoc analyses (Holm-Sidak) were used to assess multiple compar-
isons for signiﬁcance. Multiple linear regressions were used to
assess correlations between tissue weights and age of mice at
sacriﬁce. For pre-adipocyte studies, data were analyzed by Stu-
dent's t-test comparing cells derived from either visceral or sub-
cutaneous adipose depots. For all, signiﬁcance was assigned for
analyses that reached po0.05.3. Results and discussion
Using data from Jackson Labs regarding the growth rate of
C57BL/6 mice [23], we determined that male mice of this strain
reach adulthood at 6–9 months based on their general pla-
teauing of body weight and size. Among mice that reached at least
6 months of age, we show here that further advancing age is
correlated with a signiﬁcant decline in body weight (Fig. 1). TheFig. 1. Aging is associated with a loss of fat mass in C57BL/6 mice. Each plot shows the
animal at sacriﬁce (X axis). Y-axis is presented in grams and X-axis is in months of age. E
Each plot also shows the least squares regression line and R2 and p values for line
gon¼epigonadal visceral depot, Peri¼perirenal visceral depot, Inguinal¼ inguinal subcu
depot.mean weight (and SEM) of young males in our study was
31.072.7 g and that of old males was 28.571.9 g. To eliminate
potential cofounds, all animals with obvious neoplasia were cen-
sored from this study. Upon sacriﬁce, the wet weight of all tissues
was collected and nearly all visceral and subcutaneous adipose
depots showed a signiﬁcant decline in weight with age suggesting
that all were lost with age to relatively similar degrees (Fig. 1).
Brown fat weight did not signiﬁcantly correlate with age, though
this may not be surprising as its content and lineage may be more
similar to tissues such as muscle rather than WAT. For further
biochemical and cellular experiments, we chose to focus on two
groups of adipose depots: visceral (including epidydimal or peri-
renal depots) and subcutaneous (including both inguinal and
subscapular depots).
Maintenance of adipose tissue is a dynamic process as lipids are
mobilized for energy utilization through regulation of adipose
breakdown or lipolysis and also stored for future use through the
regulation of adipogenesis. Even in young animals, we found evi-
dence that the regulation of these processes differs greatly be-
tween subcutaneous and visceral adipose depots. Hormone sen-
sitive lipase (HSL) and lipoprotein lipase (LPL) hydrolyze trigly-
cerides stored in adipose tissue to their free fatty acid forms and
are rate-limiting steps in lipolysis. We found that the phosphory-
lated (active) form of HSL was relatively high in visceral adipose as
compared to subcutaneous adipose, though there was no speciﬁc
effect of age (Fig. 2). Similarly, LPL was high in visceral adipose,
though levels of this enzyme declined with age in both depots.
However, levels of the transcription factor PPARγ, which regulatescorrelation between the mass of the indicated parameter (Y axis) and age of the
ach symbol is the value obtained from an individual mouse for the given parameter.
ar regression between the indicated parameters. Body¼total body weight, Epi-
taneous depot, Subscap¼subscapular subcutaneous depot, Brown¼brown adipose
Fig. 2. Depot-dependent effects of aging on the dynamics of lipolysis and adipogenesis. A. Representative Western blots indicating samples from visceral (Visc) and sub-
cutaneous (Subc) depots. Y indicates samples from young mice, A indicates samples from aged mice and O indicates samples from old mice. B. Quantiﬁed ratio of phos-
phorylated HSL to total HSL in indicated groups; effect of age p¼0.35, effect of depot po0.001. C. Quantiﬁed levels of LPL in indicated groups normalized to relative levels of
GAPDH; effect of age po0.001, effect of depot p¼0.01. D. Quantiﬁed levels of PPARγ in indicated groups normalized to relative levels of GAPDH; effect of age p¼0.72, effect of
depot po0.001. Bars indicate average values7SEM for (n¼4) for each group. Asterisks represent signiﬁcant difference between depots at indicated age group as measured
by post-hoc analysis of ANOVA.
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eral adipose compared to subcutaneous in young and aged ani-
mals, but not old animals. Together, these data suggest relatively
high levels of lipolysis and adipogenesis in visceral adipose that
declines with age, in contrast to the relatively constant low levels
in subcutaneous adipose.
As a potential mechanism behind this difference, we focused on
oxidative stress and the accumulation of oxidative damage. Oxi-
dative stress has been suggested to play an etiological role in the
development of metabolic disorders due to actions within adipose
tissue [14,24]. In addition, 4-hydroxynonenal (4-HNE), a product of
lipid peroxidation in cells, has been associated with the lipolytic
activation in adipocytes and impaired adipogenesis [24–26]. Thus,
we predicted that the age- and depot-dependent differences in
adipose dynamics described above could be driven by alterations
in oxidative stress among these groups. In young mice, protein-
bound 4-HNE adducts in subcutaneous adipose depots were sig-
niﬁcantly lower than in visceral adipose (Fig. 3). With age there
was no effect on 4-HNE levels in visceral adipose overall, whereas
there was a small, but signiﬁcant, accumulation of 4-HNE adducts
with age in subcutaneous fat. In old animals, there was no sig-
niﬁcant difference in 4-HNE between visceral and subcutaneous
adipose tissues. One interpretation of these data may be that an-
tioxidant defenses decline with age in subcutaneous adipose
thereby allowing for increased oxidative damage. Cu/Zn super-
oxide dismutase (Sod 1) levels did decline with age, but there was
no difference between depots (Fig. 3). On the other hand, levels of
Mn superoxide dismutase (Sod 2) did not change with age, though
subcutaneous fat had lower levels overall as measured by two
factor ANOVA. Similar to these expression results, the activity of
superoxide dismutase (encompassing both Sod1 and Sod2) does
not differ with age or depot. In contrast, we found both the activity
of glutathione peroxidase and the expression of glutathioneperoxidase 1 (Gpx1) to be signiﬁcantly reduced in subcutaneous
adipose, identifying a potential primary defect that could drive the
relative accumulation of oxidative damage with age (Fig. 3).
However, these oxidative stress-related data only partially ex-
plain the age- and depot-speciﬁc differences in regulation of li-
polytic and adipogenic modulators described in Fig. 2. The acti-
vation of stress-signaling pathways mediate much of the cellular
response to oxidative stress and thus may better represent how
the cell perceives these stresses rather than the accumulation of
damage overall. Moreover, some stress signaling pathways, in-
cluding jun N-terminal kinase (JNK) and mitogen-activated protein
kinases (MAPK/ERK), have been associated with the regulation of
PPARγ and HSL [27–30]. In young mice, we found that sub-
cutaneous adipose had a signiﬁcant reduction in phosphorylation
of JNK, a marker of activation in this pathway, than did visceral
adipose (Fig. 4). This difference persisted in aged animals, but in
tissues from old animals there was no signiﬁcant difference be-
tween depots. Similar to our results measuring 4-HNE levels, there
was no signiﬁcant effect of age in visceral adipose whereas there
was a signiﬁcant increase with age in subcutaneous adipose. In-
terestingly, phosphorylation of MAPK/ERK followed a different
depot- and age-speciﬁc pattern (Fig. 4). Phosphorylation of this
pathway increased with age; however, visceral and subcutaneous
depots only differed in old animals with subcutaneous adipose
showing a signiﬁcant reduction in ERK activation. While these in
general agree with our ﬁndings regarding oxidative stress, they
again cannot fully account for the extreme disparities in lipolytic
and adipogenic markers we found that exist between adipose
depots.
We next addressed the possibility that these depot-dependent
effects could be driven by differences in metabolic demands that
exist between these tissues. The effect of mitochondrial content
and function in adipose tissue has been thought to play a
Fig. 3. Oxidative stress and damage is altered in age- and depot-dependent patterns. A. Representative Western blot of protein-bound 4-HNE in samples from visceral (Visc)
and subcutaneous (Subc) depots from indicated ages. B. Quantiﬁcation of 4-HNE measured in adipose samples; effect of age p¼0.10, effect of depot p¼0.87, depot x age
interaction p¼0.04. Letters indicate those groups that are statistically similar as measured by post-hoc analysis. C. Representative Western blot of Sod1, Sod2, and Gpx1 in
indicated groups. Y indicates samples from young mice, A indicates samples from aged mice and O indicates samples from old mice. D–F. Quantiﬁed values for Western blots
for Sod1 (D; effect of age p¼0.01, effect of depot p¼0.63), Sod2 (E; effect of age p¼0.53, effect of depot p¼0.03) and Gpx1 (F; effect of age p¼0.004, effect of depot
po0.001). All values are normalized to relative levels of GAPDH. G. Activity of Sod (effect of age p¼0.13, effect of depot p¼0.65) and H. activity of Gpx (effect of age p¼0.11,
effect of depot p¼0.002 in sample homogenates from indicated groups. Asterisks represent signiﬁcant difference between depots at indicated age group as measured by
post-hoc analysis of ANOVA. For all, bars indicate average values7SEM for (n¼4–5) for each group.
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obesity [31]. In humans, visceral adipose has been thought to have
higher metabolic rate and greater mitochondrial density than
subcutaneous fat [32]. To address the role of metabolism in the
depot-speciﬁc differences we report, we utilized primary pre-
adipocyte (PA) cultures derived from visceral or subcutaneous
depots of young mice. We chose to use primary cultures of PA
because: (1) PA contribute 15–50% of the total cellular content of
adipose; (2) are signiﬁcant contributors to chronic inﬂammation
and oxidative stress in adipose tissue; (3) they retain in vivo
characteristics of the depot from which they are derived; (4) their
activity and function change with age and contribute largely to
age-related functional changes of adipose tissue [10,20]. Moreover,changes in adipose mass occur in part through recruitment and
differentiation of an existing pool of PA into mature adipocytes.
We found that visceral- and subcutaneous-derived PA differ
dramatically in their mitochondrial bio-energetic function (Fig. 5).
We found that basal respiration (oxygen consumption rate; OCR)
of visceral depots was more than double that of pre-adipocytes
isolated from subcutaneous depots (Fig. 5B). After treating with
the mitochondrial uncoupler FCCP to assess maximal respiration
rates, visceral-derived PA again exhibited a greater than two-fold
higher rate of OCR as compared to subcutaneous-derived PA
(Fig. 5C). Lastly, the oxidative phosphorylation-coupled OCR, that
is the respiration tied directly to the production of ATP, was si-
milarly higher in visceral PA compared to subcutaneous PA
Fig. 4. Activation of stress signaling pathways with age differs between adipose depots. A. Representative Western blot and quantiﬁed ratio of phosphorylated JNK to total
JNK in indicated groups (effect of age p¼0.71, effect of depot po0.001). Y indicates samples from young mice, A indicates samples from aged mice and O indicates samples
from old mice. B. Quantiﬁed ratio of phosphorylated ERK to total ERK as measured by ELISA in indicated groups (effect of age po0.001, effect of depot p¼0.08). Bars indicate
average values7SEM for (n¼4–5) for each group. Asterisks represent signiﬁcant difference between depots at indicated age group as measured by post-hoc analysis of
ANOVA.
Fig. 5. Source of pre-adipocytes dramatically alters their mitochondrial respiration. A. Oxygen consumption rate (OCR) of pre-adipocytes derived from visceral (closed) and
subcutaneous (open) depots as measured by BOFA assay using Seahorse bioanalyzer. Symbols represent average values7SEM for (n¼8) for each group at indicated time
points. Letter A indicates addition of oligomycin, letter B indicates addition of FCCP and letter C indicates addition of antimycin A to the cellular chamber. B–D. Integrated area
under the curve (AUC) for basal oxygen consumption (B.), maximum oxygen consumption (C.) and oxidative phosphorylation-coupled oxygen consumption (D.) measured
during assay. Each circle represents AUC value calculated from an individual cell line; p value is given for t-test comparing each group.
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tochondrial) respiration in cells derived from visceral adipose de-
pots, we found little evidence for differences in mitochondrial
content as measured by the protein expression of cytochrome c or
of different constituents of electron chain complexes I–IV in total
protein homogenates from these PA lines (Fig. 6A). While not
comprehensive studies of mitochondrial density, these datasuggest fundamental differences in mitochondrial number is likely
not the reason for the depot-speciﬁc differences in PA mitochon-
drial respiration. This raises interesting possibilities for the po-
tential mechanisms including differences between depots in the
formation of complexes, difference in pools of available energetic
precursors, or possibly fundamental differences in the structure of
the mitochondria themselves that limit effectiveness of the
Fig. 6. Source of pre-adipocytes affects their oxidative stress resistance. A. Protein levels of indicated mitochondrial proteins as measured by immunoblot. Bars represent
ratio of average level of indicated protein in subcutaneous-derived pre-adipocytes compared to visceral-derived pre-adipocytes7SEM. B-C. Survival of visceral- (closed) or
subcutaneous-derived (open) pre-adipocytes following exposure to paraquat (B) or tert-butyl hydrogen peroxide (TBHP, C) at the indicated doses. Symbols represent average
values for (n¼4) individual cell lines7SEM. Asterisks indicated signiﬁcant difference between groups for indicated dose as measured by t-test.
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differences in necessary and could be key to understanding the
basic biological differences between these two physiologically
distinct white adipose depots.
We also found no difference in cell growth between cell lines
from each depot (data not shown), implying perhaps that visceral-
derived PA require greater energy production to maintain normal
growth. Somewhat consistent with this idea, we found that visc-
eral-derived PA are more sensitive to different forms of cellular
oxidative stress (Fig. 6B). When treated with either paraquat, a
redox-cycler that produces superoxide, or tert-butyl hydrogen
peroxide, subcutaneous-derived PA were better able to survive
these forms of oxidative stress than PA derived from visceral adi-
pose. Again, the mechanisms responsible for this stress resistance
are not yet clear, though reduced activation of stress signaling
pathways in subcutaneous fat would be consistent with increased
stress resistance of cells derived from this depot. This difference in
stress sensitivity might also explain the relatively high rates of
cellular senescence found in visceral adipose tissue both with
aging and obesity [7,9,10].
Contrary to our initial hypothesis, our data suggest no large
difference between visceral and subcutaneous adipose tissue in
their age-associated accumulation of oxidative damage (in the
form of 4-HNE adducts) or in their changes in enzymatic anti-
oxidant defense. Moreover, our data show that the effect of age on
both adipose depots is relatively minor, in line with at least one
previous study [33]. However, we discovered that the pattern of
activation of the stress responsive signaling pathways differed
with both age and depot with evidence that subcutaneous adipose
showed reductions in the activation of both JNK and MAPK/ERK
signaling. One interpretation of these ﬁndings may be that sub-
cutaneous adipose requires a higher threshold of oxidative stress
to initiate these stress responses. Our ﬁnding that pre-adipocytes
from subcutaneous fat are more resistant to at least two forms of
oxidant stress are supportive of this particular interpretation. How
these stress responsive pathways directly respond to oxidative
stress is still largely unknown, though there are clear roles for JNK
and ERK in metabolic stress and in particular in response to mi-
tochondrial stress [34–36]. A better understanding of how the cells
respond to oxidative stress particularly in adipose tissue could
certainly help delineate how the response to oxidative stress may
mediate some of the other physiological distinctions between
subcutaneous and visceral adipose tissue.
Mitochondrial function and oxidative phosphorylation are im-
portant to the homeostatic maintenance of WAT [37]. It was thenquite surprising to us to ﬁnd the dramatic differences in oxidative
phosphorylation of pre-adipocytes derived from two different
adipose depots. While using pre-adipocytes has some limitations
on interpreting effects on the adipose tissue as a whole, many
depot-speciﬁc characteristics are retained even after differentia-
tion to mature adipose cells [7,20]. Due to their requirement of
ATP, the depot-speciﬁc alterations with age in lipolytic and adi-
pogenic markers may be driven in part by differences in mi-
tochondrial oxidative phosphorylation between subcutaneous and
visceral adipose tissue [38,39]. In comparison to other tissues,
there is a relative dearth in information regarding changes in
mitochondrial function with age in adipose tissue. Expression of
mitochondrial proteins, including cytochrome C, Hsp60 and pyr-
uvate dehydrogenase have been reported to decline with age in
mouse visceral fat [40]. However, a proteomic-based study has
suggested that many mitochondrial/ATP-generating proteins (in-
cluding ATP synthase, pyruvate dehydrogenase and isocitrate de-
hydrogenase) are actually elevated in visceral adipose from 24
month old C57BL/6 mice compared to 12 month old mice [33]. In
line with the latter, oxygen consumption of mitochondria from
visceral adipose of old mice has been reported to be elevated
compared to that of young mice for glycolytic, though not fatty
acid, substrates [41]. Further studies are needed to both clarify
how aging affects adipose mitochondrial function and whether
this is altered by the anatomical site of the adipose tested.
While not directly tested, our ﬁndings may also offer some
insight into the purported metabolic beneﬁts of subcutaneous
adipose tissue versus its visceral counterpart. Our ﬁndings suggest
less remodeling (i.e., breakdown and biogenesis) of subcutaneous
adipose in mice at least until they become very old. Our data also
suggest both relatively lower metabolic rates in cells derived from
subcutaneous adipose and reduced activation of stress signaling in
this adipose depot. An interpretation of these data together might
be that subcutaneous adipose is far more stable than visceral
adipose. This relative “stability” of subcutaneous adipose might
then prevent lipid release, mitochondrial dysfunction, and cellular
dysfunction thereby providing metabolic beneﬁt in contrast to
visceral adipose which has been identiﬁed as contributing to
metabolic dysfunction. Thus, identifying ways to improve or en-
hance the beneﬁts of maintaining, or promoting, subcutaneous
adipose tissue with agevﬁts in line with the goal of extending the
period of healthy aging in humans.
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